Segnalazione dalla newsletter Public Health

 COVID-19: Commission to support clinical trials via ESI

The Commission has signed a grant of 1 M€ to support the conduct of a clinical trial using Raloxifene for patients suffering from COVID-19. Since January 2020, a number of projects to repurpose existing molecules have been selected for funding through different EU research calls in a competitive process.

This grant has been signed under the Emergency Support Instrument (ESI), which provides EU funding to support the generation of clinical evidence that would support an application for a new marketing authorisation. This would repurpose an existing medicinal product to treat COVID-19 patients. (...) 

Also, see:
•    EU coronavirus research and innovation website 

(...)